COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL (CRISP)

The Royal Wolverhampton Hospitals NHS Trust

Status: Completed

Conditions: Covid19; Rheumatic Diseases

Treatments: Other: Questionnaire

Study type: Interventional

Funder types: Other

Identifiers

NCT04542031

2020COV113

Details and patient eligibility

About

The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology of COVID-19 in the rheumatological population is largely unknown large case registries are beginning to show potential drug treatment interactions. Strict self-isolation (shielding) has been recommended for those deemed 'high risk' although its impact on the likelihood of COVID-19 infection and health related quality of life (HRQoL) is unclear.

The study aims to explore how this unprecedented situation has impacted the Trust patients primarily evaluating prevalence of the infection, effect of stringent social distancing (shielding) and Quality of Life (QOL). This will be done via a voluntary questionnaire, sent via text messaging at 6 and 12 months.

Enrollment: 1,010 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All rheumatology patients under active follow up at the Royal Wolverhampton Trust with a validated mobile telephone number

Exclusion criteria

• Patients without a validated mobile phone number linked to their hospital record

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,010 participants in 1 patient group

Survey

Other group

Description:

Survey to be distributed at 6 and 12 months

Treatment:

Other: Questionnaire